The Long Non-Coding RNA Landscape of Atherosclerotic Plaques

Area of Science:

• Biomedical Science
• Molecular Biology
• Cardiovascular Research

Background:

• Cardiovascular diseases are the leading global cause of mortality.
• Atherosclerosis, a complex arterial disease, stems from disrupted lipid homeostasis and inflammation, leading to plaque formation.
• Long non-coding RNAs (lncRNAs), RNA molecules over 200 nucleotides, are increasingly implicated in disease pathogenesis.

Purpose of the Study:

• To highlight the critical role of lncRNAs in atherosclerosis.
• To emphasize the need for further research into the molecular mechanisms of atherosclerotic plaque formation.
• To advocate for the standardization of experimental approaches and validation of lncRNAs as cardiovascular disease biomarkers.

Main Methods:

• Review of current scientific literature on lncRNAs and atherosclerosis.
• Analysis of existing evidence linking lncRNA deregulation to disease development.
• Discussion of the challenges and future directions in the field.

Main Results:

• lncRNA expression dysregulation is associated with various diseases, including atherosclerosis.
• Understanding lncRNA's role in atherosclerotic plaque development is crucial but remains incomplete.
• Standardized methods are needed to validate lncRNAs as potential biomarkers for cardiovascular diseases.

Conclusions:

• Further research into the molecular basis of atherosclerosis is a high priority.
• lncRNAs represent a promising area for understanding and potentially treating cardiovascular diseases.
• Validating lncRNAs as biomarkers could facilitate clinical translation for cardiovascular disease diagnosis and management.